VT News
John O'Shea

John O'Shea

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • Charity rowing team mistaken for 'illegal migrants' by MP, leading to multiple interventions, but crew uses attention to highlight fundraising for motor neurone disease research.
  • Chicago approves historic 2025 river swim event, raising funds for ALS research and youth swim education.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • Charity rowing team mistaken for 'illegal migrants' by MP, leading to multiple interventions, but crew uses attention to highlight fundraising for motor neurone disease research.
  • Chicago approves historic 2025 river swim event, raising funds for ALS research and youth swim education.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from John O'Shea

Top Topics

Trending in U.S.

World

Sport